Literature DB >> 14726374

SCL is required for normal function of short-term repopulating hematopoietic stem cells.

David J Curtis1, Mark A Hall, Leonie J Van Stekelenburg, Lorraine Robb, Stephen M Jane, C Glenn Begley.   

Abstract

The stem cell leukemia (SCL) gene is essential for the development of hematopoietic stem cells in the embryo. Here, we used a conditional gene targeting approach to examine the function of SCL in adult hematopoietic stem cells (HSCs). Flow cytometry of bone marrow from SCL-deleted mice demonstrated a 4-fold increase in number of Lin(neg) c-kit(+) Sca-1(+) cells. Despite this increase in the number of phenotypic HSCs, competitive repopulation assays demonstrated a severe multilineage defect in repopulation capacity by SCL-deleted bone marrow cells. SCL-heterozygous cells also showed a mild repopulation defect, thus suggesting haploinsufficiency of SCL. The transplantation defect of SCL-deleted cells was observed within 4 weeks of transplantation, indicating a defect in a multipotent progenitor or short-term repopulating HSCs. Although the defect persisted in secondary transplants, it remained relatively stable, suggesting that SCL was not required for self-renewal of the HSCs. Generation of SCL-deleted cells within SCL-wild-type mice rescued the early repopulating defect. Together, our results suggest that SCL is required for the normal function of short-term repopulating HSCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726374     DOI: 10.1182/blood-2003-09-3202

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Authors:  Steffen Koschmieder; Frank Rosenbauer; Ulrich Steidl; Bronwyn M Owens; Daniel G Tenen
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

2.  Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.

Authors:  Mark A Hall; Nicholas J Slater; C Glenn Begley; Jessica M Salmon; Leonie J Van Stekelenburg; Matthew P McCormack; Stephen M Jane; David J Curtis
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties.

Authors:  Michelle B Bowie; David G Kent; Brad Dykstra; Kristen D McKnight; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

Review 4.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

5.  The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.

Authors:  S Ogilvy; R Ferreira; S G Piltz; J M Bowen; B Göttgens; A R Green
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

Review 6.  E and ID proteins branch out.

Authors:  Barbara L Kee
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

7.  Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.

Authors:  Brenda J Chyla; Isabel Moreno-Miralles; Melissa A Steapleton; Mary Ann Thompson; Srividya Bhaskara; Michael Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

8.  Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.

Authors:  E Delabesse; S Ogilvy; M A Chapman; S G Piltz; B Gottgens; A R Green
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

9.  Modeling reveals bistability and low-pass filtering in the network module determining blood stem cell fate.

Authors:  Jatin Narula; Aileen M Smith; Berthold Gottgens; Oleg A Igoshin
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

Review 10.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.